YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defectQian Lei, Luoting Yu, Tinghong Ye et al.|Cell Death and Disease|2018Cited by 65
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChao Gao, Yuquan Wei, Tinghong Ye et al.|Scientific Reports|2016Cited by 48
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agentsKai Ran, Luoting Yu, Qian Lei et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 39
Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profilesLu Xiong, Ningyu Wang, Kun-Lin Liu et al.|RSC Advances|2018Cited by 25
A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine modelsChao Gao, Tinghong Ye, Ningyu Wang et al.|Biomedicine & Pharmacotherapy|2017Cited by 6